Emergent BioSolutions
EBS
#6519
Rank
A$1.10 B
Marketcap
A$20.74
Share price
5.70%
Change (1 day)
25.81%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: A$1.10 Billion

As of January 2026 Emergent BioSolutions has a market cap of A$1.10 Billion. This makes Emergent BioSolutions the world's 6519th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026A$1.10 B11.78%
2025A$0.99 B37.43%
2024A$0.72 B294.17%
2023A$0.18 B-78.89%
2022A$0.86 B-73.16%
2021A$3.22 B-47.77%
2020A$6.17 B55.02%
2019A$3.98 B-7.53%
2018A$4.30 B45.07%
2017A$2.96 B60.97%
2016A$1.84 B-14.75%
2015A$2.16 B72.5%
2014A$1.25 B32.92%
2013A$0.94 B70.5%
2012A$0.55 B-6.24%
2011A$0.59 B-26.98%
2010A$0.80 B73.36%
2009A$0.46 B-57.88%
2008A$1.10 B543.11%
2007A$0.17 B-55.93%
2006A$0.39 B

End of Day market cap according to different sources

On Jan 7th, 2026 the market cap of Emergent BioSolutions was reported to be:

A$1.09 Billion
by Nasdaq info icon info icon
A$1.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
A$404.80 B 36,478.54%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$0.73 B-33.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$152.67 B 13,695.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
A$2.75 B 148.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$214.49 B 19,282.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$55.47 B 4,912.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
A$21.97 M-98.01%๐Ÿ‡บ๐Ÿ‡ธ USA